Lawmakers are asking questions about the process that led the Food and Drug Administration to approve a controversial drug for Alzheimer’s disease. The latest is House Representative Katie Porter (D-CA), who released an open letter late Tuesday calling for the inspector general of Health and Human Services to…
from Gizmodo https://ift.tt/2Viv4l1
